GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $686,000 | -4.2% | 46,984 | -6.8% | 0.00% | 0.0% |
| Q3 2020 | $716,000 | +4.1% | 50,434 | +7.8% | 0.00% | 0.0% |
| Q2 2020 | $688,000 | +256.5% | 46,784 | 0.0% | 0.00% | +200.0% |
| Q1 2020 | $193,000 | -15.0% | 46,784 | -1.1% | 0.00% | 0.0% |
| Q4 2019 | $227,000 | -51.3% | 47,284 | -38.5% | 0.00% | -66.7% |
| Q3 2019 | $466,000 | -23.0% | 76,834 | -17.6% | 0.00% | 0.0% |
| Q2 2019 | $605,000 | -8.5% | 93,266 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $661,000 | +45.9% | 93,266 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $453,000 | -34.0% | 93,266 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $686,000 | +11.7% | 93,266 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $614,000 | +17.2% | 96,266 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $524,000 | +34.7% | 96,266 | +3.2% | 0.00% | +33.3% |
| Q4 2017 | $389,000 | -9.1% | 93,266 | +110.0% | 0.00% | 0.0% |
| Q3 2017 | $428,000 | – | 44,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |